Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma

BACKGROUND & OBJECTIVES: Pancreatic ductal adenocarcinoma remains an extremely malignant tumor having a poor prognosis. The 5-year survival rate of PDAC is related to its stage (about 80% for stage I vs 20% for other stages). However, detection of PDAC in an early stage is difficult due to the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yingying, Zhao, Rui, Guo, Kai, Ren, Shuai, Zhang, Yaping, Lu, Zipeng, Tian, Lei, Li, Tao, Chen, Xiao, Wang, Zhongqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807510/
https://www.ncbi.nlm.nih.gov/pubmed/35127469
http://dx.doi.org/10.3389/fonc.2021.744667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807510/
https://www.ncbi.nlm.nih.gov/pubmed/35127469
http://dx.doi.org/10.3389/fonc.2021.744667

Ejemplares similares